Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Natus Medical Inc (NTUS)

Natus Medical Inc (NTUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,133,911
  • Shares Outstanding, K 34,581
  • Annual Sales, $ 473,440 K
  • Annual Income, $ 13,180 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.22
  • Price/Sales 2.39
  • Price/Cash Flow 16.34
  • Price/Book 2.65
  • Price/Earnings ttm 25.95
  • Earnings Per Share ttm 1.26
  • Most Recent Earnings $0.22 on 05/05/22
  • Next Earnings Date 08/04/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 0.32
  • Number of Estimates 1
  • High Estimate 0.32
  • Low Estimate 0.32
  • Prior Year 0.29
  • Growth Rate Est. (year over year) +10.34%

Price Performance

See More
Period Period Low Period High Performance
1-Month
31.10 +5.98%
on 06/21/22
33.25 -0.87%
on 06/28/22
+1.88 (+6.05%)
since 06/17/22
3-Month
30.47 +8.17%
on 06/16/22
33.57 -1.82%
on 04/26/22
-0.46 (-1.38%)
since 04/20/22
52-Week
20.90 +57.69%
on 02/07/22
33.93 -2.86%
on 04/18/22
+8.45 (+34.48%)
since 07/20/21

Most Recent Stories

More News
Novanta Set to Join S&P MidCap 400; Six Flags Entertainment to Join S&P SmallCap 600

/PRNewswire/ -- Novanta Inc. (NASD: NOVT) will replace Six Flags Entertainment Corp. (NYSE: SIX) in the S&P MidCap 400, and Six Flags will replace Natus...

SPGI : 485.77 (+0.51%)
NOVT : 174.17 (-0.03%)
NTUS : 32.96 (+0.09%)
SIX : 32.00 (-3.44%)
ArchiMed completes acquisition of Natus Medical Incorporated for $1.2 billion total equity value

MIDDLETON, Wis., July 21, 2022 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical...

NTUS : 32.96 (+0.09%)
INVESTIGATION NOTICE: Halper Sadeh LLP Investigates USWS, GDST, NTUS, CMAX

/PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

USWS : 7.41 (+2.63%)
GDST : 11.25 (unch)
NTUS : 32.96 (+0.09%)
CMAX : 1.97 (-4.37%)
NATUS MEDICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Natus Medical Incorporated - NTUS

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Natus Medical Incorporated (NasdaqGS: NTUS)...

NTUS : 32.96 (+0.09%)
NATUS MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Natus Medical Incorporated - NTUS

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Natus Medical Incorporated (NasdaqGS: NTUS)...

NTUS : 32.96 (+0.09%)
Natus Medical Announces First Quarter 2022 Financial Results

 Q1-2022 Key ResultsRevenue (millions)$119.8 • Total revenue increased 4.2% compared to Q1 2021• Generated $8.9 million in operating cash flowGAAP...

NTUS : 32.96 (+0.09%)
Why Natus Medical Stock Surged Today

A suitor wants to take the company private.

NTUS : 32.96 (+0.09%)
Southwest Gas, Bank of America rise; Schwab, DiDi fall

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday:

NTUS : 32.96 (+0.09%)
BAC : 41.33 (-1.03%)
SYF : 55.06 (+0.11%)
TSLA : 242.84 (-2.47%)
SCHW : 70.96 (+0.03%)
NTUS Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Natus Medical Incorporated Is Fair to Shareholders

Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of Natus Medical Incorporated (NASDAQ: NTUS) to an affiliate of ArchiMed for $33.50 in cash per share is fair to Natus Medical...

NTUS : 32.96 (+0.09%)
Natus Medical Incorporated to be acquired by ArchiMed Group for $33.50 per share in cash

Highlights: •        Transaction values Natus Medical, Incorporated at approximately $1.2 billion total equity value•        Pre-announces preliminary...

NTUS : 32.96 (+0.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Natus Medical Incorporated is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care. Product offerings include computerized...

See More

Key Turning Points

3rd Resistance Point 33.30
2nd Resistance Point 33.19
1st Resistance Point 33.07
Last Price 32.96
1st Support Level 32.84
2nd Support Level 32.73
3rd Support Level 32.61

See More

52-Week High 33.93
Last Price 32.96
Fibonacci 61.8% 28.95
Fibonacci 50% 27.42
Fibonacci 38.2% 25.88
52-Week Low 20.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar